CD8+CD28− T cells could represent a pathogenic T-cell subset in SSc, especially in the early stage of the disease, being increased in blood and skin SSc patients and correlating with disease duration and skin fibrosis extent. This evidence concerns the gene CD8A and systemic sclerosis.